ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

5.65

-0.73 (-11.44%)

Aug 20, 2026, 2:36 PM EDT - Market open

ARS Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	116.93	84.28	89.15	0.03	1.32	5.51
Revenue Growth	4.08%	-5.46%	297063.33%	-97.72%	-76.10%	-69.13%
Gross Profit	68.22	50.67	68.59	-20.24	-15.8	-14.77
Operating Income	-216.27	-179.45	-3.08	-67.52	-34.46	-19.45
Net Income	-215.43	-171.3	8	-54.37	-34.68	-20.24
Earnings Per Share	-2.18	-1.74	0.08	-0.57	-0.87	-0.70
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	95.29	72.19	7.26	0.03	1.32	5.51
Rest of World	18.96	12.09	81.89	-	-	-
Total	116.93	84.28	89.15	0.03	1.32	5.51

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	143.85	244.99	314.02	228.36	274.38	60.06
Total Debt	171.6	168.51	69.38	0.27	0.48	9.03
Net Cash (Debt)	-27.76	76.47	244.64	228.09	273.9	51.03
Net Cash Growth	-	-68.74%	7.26%	-16.73%	436.74%	251.86%
Net Cash Per Share	-0.28	0.78	2.39	2.40	6.86	1.77

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-196.41	-170.87	13.55	-59.27	-40.08	-17.56
Capital Expenditures	-0.2	-0.34	-0.56	-0.18	-0.2	-0.06
Free Cash Flow	-196.6	-171.21	12.99	-59.44	-40.28	-17.62
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	58.35%	60.13%	76.94%	-	-	-268.20%
Operating Margin	-184.96%	-212.92%	-3.46%	-225066.67%	-2618.54%	-353.32%
Pretax Margin	-184.31%	-203.35%	9.29%	-181216.67%	-2635.41%	-367.65%
Profit Margin	-184.25%	-203.25%	8.97%	-181216.67%	-2635.41%	-367.65%
FCF Margin	-168.14%	-203.14%	14.57%	-198136.67%	-3060.56%	-319.94%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	128.20	-	-	-
P/FCF Ratio	-	-	78.96	-	-	-
PS Ratio	4.89	13.66	11.50	17535.50	607.80	-